(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges
Crossref DOI link: https://doi.org/10.1186/s12885-016-2060-4
Published Online: 2016-01-19
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schneider, Tatiana C.
Kapiteijn, Ellen
van Wezel, Tom
Smit, Jan W. A.
van der Hoeven, Jacobus J. M.
Morreau, Hans
License valid from 2016-01-19